Welcome to Mobilarian Forum - Official Symbianize forum.

Join us now to get access to all our features. Once registered and logged in, you will be able to create topics, post replies to existing threads, give reputation to your fellow members, get your own private messenger, and so, so much more. It's also quick and totally free, so what are you waiting for?

FDA Approves Inhaled Insulin Drug Afrezza

Alexhost
M 0

marckos

Abecedarian
Member
Access
Joined
Jun 25, 2014
Messages
195
Reaction score
31
Points
18
grants
₲9,107
10 years of service
June 27, 2014 -- The FDA has approved inhaled insulin to treat type 1 and type 2 diabetes.

The insulin, called Afrezza, is a rapid-acting insulin and is meant to be taken at mealtime or soon after.

"Today's approval broadens the options available" for delivering insulin in people with diabetes, Jean-Marc Guettier, MD, director of the FDA's Division of Metabolism and Endocrinology Products, says in a news release.

The FDA estimates that 18.1 million people have diabetes. About 7 million more are undiagnosed, the agency says.

This is the third time the drug was up for FDA approval. Its maker, MannKind Corporation, conducted additional safety studies after the first two attempts.

Patients with type 1 diabetes will need to use the drug in combination with long-acting insulin. Patients with type 2 diabetes will use it in combination with oral medications.

Afrezza carries a warning as it may cause a sudden tightening of the chest. It is not recommended for people with asthma or COPD. It is also not recommended for people that smoke or for the treatment of diabetic ketoacidosis.
 
Top Bottom